An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV ...

A leading cause of birth defects is a virus that many expectant parents have never heard about. That may change soon thanks to the advocacy of parents whose children suffered birth defects due to the ...

Cytomegalovirus or CMV, is a member of the herpes virus family. Coming into contact with the CMV virus is a common occurrence and is typically harmless to the general population. A CMV infection ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects such as cytomegalovirus (CMV), following its failure to reach the primary ...

Lily Belle never got to grow up, be a sister or experience the world, writes Arissa Viering. But with the right awareness and medical research, we might have been able to save her life. iStock ...

Researchers have uncovered a compelling potential link between a chronic gut infection caused by a common virus and the ...

Moderna said its cytomegalovirus (CMV) vaccine, mRNA-1647, failed to prevent infection in women of childbearing age in a large Phase 3 trial, prompting the company to end its congenital CMV program.

Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.

The study, titled “ Strategic Help with Immunoglobulin to Enhance protection against Late Disease (CMV) ” or SHIELD, is a prospective, randomized, controlled multicenter investigator-initiated study ...

A new mRNA vaccine in phase 3 clinical trials is better at triggering the immune system to fight cytomegalovirus infection.